| Description |
The conference series aims to incorporate basic, translational and clinical aspects of stem cell research into a single framework. The mechanisms that generate and maintain mammalian embryonic and tissue-specific stem cell populations will be discussed, as will the application of this knowledge to regenerative medicine and cancer biology. In particular, the role of induced pluripotentcy and cancer stem cells will be highlighted. Non-mammalian model systems will be included as they provide strong forward genetics, and also opportunities for in vivo pharmacological screening. The goal is to give participants an overview of the model systems and scientific and logistic framework involved in gaining and exploiting basic knowledge of stem cell biology.
Speakers
Confirmed Speaker
Ernest Arenas, Karolinska Institute, Sweden
Eduard Batlle, Institute for Research in Biomedicine, Spain
Oliver Brüstle, Institute of Reconstructive Neurobiology, Germany
Hans Clevers, Hubrecht Institute, Germany
Magdalena Götz, LMU Munich and Helmholtz Center Munich, Germany
Jürgen Knoblich, Institute of Molecular Biotechnology, Austria
Stuart H. Orkin, Harvard Medical School, USA
Roger Patient, University of Oxford, United Kingdom
Timm Schroeder, Helmholtz Zentrum Muenchen - German Research Centre for Environmental Health (GmbH), Germany
Lorenz Studer, Memorial Sloan-Kettering Cancer Center, USA
Toshio Suda, Keio University, Japan
Andreas Trumpp, German Cancer Research Center (DKFZ), Germany
Tariq Enver, Weatherall Institute of Molecular Medicine, United Kingdom
Alexander Medvinsky, University of Edinburgh, United Kingdom
Cedric Blanpain, University of Brussels, Belgium
Paul Frenette, Mount Sinai School of Medicine, USA
Margaret Buckingham, Pasteur Institute, France
Registration and Payment
Registration will open soon.
Meanwhile, if you are interested in this conference and would like to receive updates, please send an email to the mailing list. You will then be informed once the registration is open or new information is available.
Abstract Submission
Each session will start with a keynote address, and contain ca. 3 additional featured speakers. In addition, 1-2 short talks will be included in each session, based on selected abstracts. In addition, a full afternoon will be dedicated to poster presentations.
The overall schedule will be:
* Day 1: Welcome, Evening session
* Day 2: Morning session, Posters, Evening session
* Day 3: 3 sessions, followed by dinner with entertainment
* Day 4: morning session
The program will be organised into the following sessions:
* 1. Embryonic Stem Cells and Reprogramming
* 2. Hematopoiesis
* 3. Tissue Stem Cells I. Epithelial stem cells
* 4. Tissue Stem Cells II. Other tissues
* 5. Non-mammalian model systems
* 6. Cancer Stem Cells
* 7. Regeneration
General Information
EMBL Registration Fee Fellowships have been made available through EMBL's Corporate Partnership Programme. Once you have submitted your abstract, you can apply for an EMBL Registration Fee Fellowship. Please prepare a short explanation (255 characters) to indicate why you should be selected.
|
|
